Health - Google News: Dynavax Falls After Vaccine Fails to Win Panel Backing - Bloomberg

Health - Google News Google News

Dynavax Falls After Vaccine Fails to Win Panel Backing - Bloomberg Nov 16th 2012, 12:54 Dynavax Falls After Vaccine Fails to Win Panel Backing Bloomberg Dynavax Technologies Corp. (DVAX) tumbled the most in four years after its hepatitis B vaccine Heplisav failed to win the backing of U.S. regulatory advisers as the drugmaker seeks to bring its first product to market. Dynavax fell 50 percent to $2.33 at 9:34 ... Dynavax share price wilts after FDA panel snubFierceBiotech FDA panel concerned about safety of Dynavax's hep B vaccineFierceVaccines FDA Panel Wants More Info About Hep B VaccineMedPage Today Reuters -Minyanville.com -Businessweek all 55 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: